grade
pharmaceutical primary standard
vapor density
7.52 (vs air)
API family
triacetin
autoignition temp.
809 °F
expl. lim.
1.05 %, 189 °F, 7.73 %, 215 °F
manufacturer/tradename
USP
refractive index
n25/D 1.429-1.431 (lit.)
bp
258 °C (lit.)
mp
3 °C (lit.)
density
1.16 g/mL at 25 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
CC(=O)OCC(COC(C)=O)OC(C)=O
InChI
1S/C9H14O6/c1-6(10)13-4-9(15-8(3)12)5-14-7(2)11/h9H,4-5H2,1-3H3
InChI key
URAYPUMNDPQOKB-UHFFFAOYSA-N
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Triacetin USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
Still not finding the right product?
Explore all of our products under 三醋精
存储类别
10 - Combustible liquids
flash_point_f
298.4 °F - closed cup
flash_point_c
148 °C - closed cup
Monice Zondlo Fiume
International journal of toxicology, 22 Suppl 2, 1-10 (2003-10-14)
Triacetin, also known as Glyceryl Triacetate, is reported to function as a cosmetic biocide, plasticizer, and solvent in cosmetic formulations, at concentrations ranging from 0.8% to 4.0%. It is a commonly used carrier for flavors and fragrances. Triacetin was affirmed
Hywel D Williams et al.
Journal of pharmaceutical sciences, 103(6), 1734-1746 (2014-04-18)
The current study determined the extent to which the desorption of lipid-based formulations (LBFs) from a mesoporous magnesium aluminometasilicate (Neusilin®-US2) carrier is governed by drug properties, LBF composition, and LBF-to-adsorbent ratio. A secondary objective was to evaluate the impact of
Soon-Seok Hong et al.
International journal of pharmaceutics, 483(1-2), 142-150 (2015-02-11)
A high drug-loading capacity is a critical factor for the clinical development of liposomal formulations. The accommodation of hydrophobic drugs within the liposomal membrane is often limited in saturated phosphatidylcholine (PC)-based liposomes owing to the rigidity of the lipid acyl
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 1675007-1G | 04061838749611 |